Have a feature idea you'd love to see implemented?
Let us know!
QURE uniQure NV
Price (delayed)
$6.435
Market cap
$313.37M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$5.93
Enterprise value
$559.93M
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline
Highlights
The gross profit has soared by 183% from the previous quarter but it has plunged by 99% YoY
The gross margin has soared by 157% since the previous quarter but it has dropped by 95% year-on-year
The equity has shrunk by 73% YoY and by 34% QoQ
The quick ratio is down by 38% year-on-year and by 26% since the previous quarter
Key stats
What are the main financial stats of QURE
Market
Valuations
Earnings
Shares outstanding
48.7M
Market cap
$313.37M
Enterprise value
$559.93M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.22
Price to sales (P/S)
11.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
20.21
Revenue
$27.71M
EBIT
-$216.72M
EBITDA
-$204.63M
Free cash flow
-$110.6M
Per share
Balance sheet
Liquidity
EPS
-$5.93
Free cash flow per share
-$2.27
Book value per share
$2
Revenue per share
$0.57
TBVPS
$13.35
Total assets
$730.85M
Total liabilities
$633.74M
Debt
$534.44M
Equity
$97.11M
Working capital
$511.5M
Debt to equity
5.5
Current ratio
7.36
Quick ratio
6.61
Net debt/EBITDA
-1.2
Margins
Efficiency
Dividend
EBITDA margin
-738.6%
Gross margin
4.3%
Net margin
-1,027.5%
Operating margin
-872.9%
Return on assets
-35.5%
Return on equity
-158.1%
Return on invested capital
-23.4%
Return on capital employed
-33.3%
Return on sales
-782.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
QURE stock price
How has the uniQure stock price performed over time
Intraday
-3.23%
1 week
-0.54%
1 month
27.43%
1 year
7.25%
YTD
-4.95%
QTD
30.53%
Financial performance
How have uniQure's revenue and profit performed over time
Revenue
$27.71M
Gross profit
$1.18M
Operating income
-$241.86M
Net income
-$284.69M
Gross margin
4.3%
Net margin
-1,027.5%
The gross profit has soared by 183% from the previous quarter but it has plunged by 99% YoY
The gross margin has soared by 157% since the previous quarter but it has dropped by 95% year-on-year
The company's revenue has shrunk by 75% YoY but it rose by 46% QoQ
The net income has dropped by 52% year-on-year but it rose by 4.1% since the previous quarter
Growth
What is uniQure's growth rate over time
Valuation
What is uniQure stock price valuation
P/E
N/A
P/B
3.22
P/S
11.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
20.21
The company's EPS has shrunk by 51% YoY but it rose by 4.5% QoQ
QURE's P/B is 95% above its last 4 quarters average of 1.7 but 8% below its 5-year quarterly average of 3.6
The equity has shrunk by 73% YoY and by 34% QoQ
The P/S is 86% lower than the 5-year quarterly average of 82.4 but 5% higher than the last 4 quarters average of 11.1
The company's revenue has shrunk by 75% YoY but it rose by 46% QoQ
Efficiency
How efficient is uniQure business performance
The ROA has contracted by 39% YoY and by 2% from the previous quarter
The company's return on sales rose by 38% QoQ
The return on invested capital has increased by 35% year-on-year and by 10% since the previous quarter
The return on equity has declined by 30% since the previous quarter
Dividends
What is QURE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for QURE.
Financial health
How did uniQure financials performed over time
QURE's total assets is 15% greater than its total liabilities
The quick ratio is down by 38% year-on-year and by 26% since the previous quarter
The current ratio has contracted by 34% YoY and by 22% from the previous quarter
The equity has shrunk by 73% YoY and by 34% QoQ
The debt to equity is up by 49% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.